Last10K.com

Enveric Biosciences, Inc. (ENVB) SEC Filing 8-K Material Event for the period ending Tuesday, May 3, 2022

Enveric Biosciences, Inc.

CIK: 890821 Ticker: ENVB

View differences made from one to another to evaluate Enveric Biosciences, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Enveric Biosciences, Inc..

Continue

Assess how Enveric Biosciences, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Enveric Biosciences, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2022 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

Tools

Financial Statements, Disclosures and Schedules

Inside this 8-K Corporate News

Ticker: ENVB
CIK: 890821
Form Type: 8-K Corporate News
Accession Number: 0001493152-22-012127
Submitted to the SEC: Wed May 04 2022 5:12:42 PM EST
Accepted by the SEC: Wed May 04 2022
Period: Tuesday, May 3, 2022
Industry: Semiconductors And Related Devices
Events:
  1. Event for Officers

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/envb/0001493152-22-012127.htm